Monthly injection as a future maintenance option
The discussion noted Amgen and Pfizer are working on injectable GLP-1s that could be dosed monthly, representing a potential future direction for maintenance therapy.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.